Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × Mesna × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 11 Lymphoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 10 Hodgkin Disease 7 Sarcoma 6 Hematologic Neoplasms 6 Neoplasms 5 Myelodysplastic Syndromes 5 Leukemia, Myeloid, Acute 5 Neuroblastoma 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Myeloproliferative Disorders 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Vomiting 2 Testicular Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Nausea 2 Thalassemia 1 Teratoma 1 Seminoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 24 Whole-Body Irradiation 19 Mycophenolic Acid 19 Tacrolimus 16 Busulfan 16 ruxolitinib 15 Peripheral Blood Stem Cell Transplantation 14 Antilymphocyte Serum 14 fludarabine 13 Melphalan 12 Cyclosporine 10 thymoglobulin 9 Methotrexate 9 Sirolimus 6 Etoposide 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 Azacitidine 4 pomalidomide 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 parsaclisib 2 itacitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡